)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Oxygenta Pharmaceutical
Oxygenta Pharmaceutical (524636) investor relations material
Oxygenta Pharmaceutical Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 25/26 earnings summary23 May, 2026
Executive summary
Audited financial results for the quarter and year ended March 31, 2026, were approved, showing continued losses but some operational improvements year-over-year.
Board approved appointments of two new directors and a new internal auditor, and authorized steps for the upcoming AGM.
Statutory auditors issued an unmodified opinion on the financial statements.
Financial highlights
Revenue from operations for FY26 was ₹11,298.19 lakhs, up from ₹10,929.86 lakhs in FY25.
Net loss for FY26 was ₹1,704.63 lakhs, compared to a net loss of ₹1,040.55 lakhs in FY25.
Q4 FY26 revenue was ₹4,961.40 lakhs, nearly flat compared to Q4 FY25 at ₹4,946.66 lakhs.
Loss before tax for Q4 FY26 was ₹127.97 lakhs, an improvement from ₹379.93 lakhs loss in Q4 FY25.
Basic and diluted EPS for FY26 stood at ₹(4.75), down from ₹(2.86) in FY25.
Outlook and guidance
The company is prioritizing compliance and transparency, especially regarding MSME creditor identification and bill-to-bill adjustments.
Focus remains on operational improvements and addressing outstanding reporting issues.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Oxygenta Pharmaceutical
- Revenue rose but net losses widened in Q3 FY26; compliance and creditor processes are ongoing.524636
Q3 25/264 Feb 2026 - Revenue surged in FY25, but losses deepened amid compliance and reporting challenges.524636Q4 24/2520 Nov 2025
- Q3 FY25 revenue surged, but losses deepened and compliance issues remain under review.524636Q3 24/2520 Nov 2025
- Q2 FY25 revenue grew and net loss narrowed, with key statutory and compliance actions taken.524636Q2 24/2520 Nov 2025
- Q1 FY25 revenue up, net loss narrows, equity raised via share allotment; compliance issues persist.524636Q1 24/2520 Nov 2025
- Revenue rose modestly, but losses widened; new CFO appointed and compliance efforts ongoing.524636Q2 25/267 Nov 2025
- Q1 FY26 saw higher revenue but a deeper net loss, with new auditor and compliance appointments.524636Q1 25/2619 Aug 2025
Next Oxygenta Pharmaceutical earnings date
Q1 26/274 Aug, 2026
Oxygenta Pharmaceutical
Next Oxygenta Pharmaceutical earnings date
Q1 26/274 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage